IDEX/$IEX

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About IDEX

Idex manufactures pumps, flow meters, valves, and fluidic systems for customers in a variety of end markets, including industrial, fire and safety, life science, and water. The firm's business is organized into three segments: fluid and metering technologies, health and science technologies, and fire and safety and diversified products. Based in Lake Forest, Illinois, Idex has manufacturing operations in over 20 countries and has over 7,000 employees. The company generated $3.3 billion in revenue in 2024.

Ticker

$IEX

Primary listing

NYSE

Industry

Machinery

Employees

9,000

ISIN

US45167R1041

IDEX Metrics

BasicAdvanced
$14B
29.26
$6.30
1.06
$2.78
1.54%

What the Analysts think about IDEX

Analyst ratings (Buy, Hold, Sell) for IDEX stock.

Bulls say / Bears say

IDEX Corporation's acquisition of Mott Corporation for $1 billion in September 2024 enhances its applied materials science technology capabilities, potentially driving growth in high-value markets such as semiconductor fabrication and medical technologies. (businesswire.com)
The company's Fluid & Metering Technologies segment showed resilience with a 3% organic revenue increase in Q4 2024, driven by strong demand in the North American municipal market, indicating robust business fundamentals. (nasdaq.com)
IDEX's consistent dividend payments, including a recent quarterly dividend of $0.71 per share announced in June 2025, reflect financial stability and a commitment to returning value to shareholders. (marketbeat.com)
The Health & Science Technologies segment experienced a 7% organic revenue decline in 2024, attributed to reduced demand across life sciences and semiconductor markets, which could impact overall profitability. (nasdaq.com)
Rising selling, general, and administrative expenses, which increased by 14% year-over-year in Q4 2024, may pressure IDEX's profit margins if not effectively managed. (nasdaq.com)
Citigroup lowered its price target for IDEX from $264.00 to $201.00 in April 2025, suggesting potential concerns about the company's near-term growth prospects. (americanbankingnews.com)
Data summarised monthly by Lightyear AI. Last updated on 9 Jul 2025.

IDEX Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

IDEX Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $IEX

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

Jul25
IDEX
Dividend·Payment
$0.71Per share
FAQs